The burden of psoriasis is not determined by disease severity only

Journal of Investigative Dermatology Symposium Proceedings

Volumn 9, Issue 2, 2004, Pages 131-135

  Heydendael, Vera M R ^a,b   De Borgie, Corianne A J M ^a   Spuls, Phyllis I ^a   Bossuyt, Patrick M M ^a   Bos, Jan D ^a   De Rie, Menno A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

PASI; Quality of life; SF 36

Indexed keywords

CYCLOSPORIN; METHOTREXATE;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DESQUAMATION; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOME SURVEY SHORT FORM 36; MENTAL HEALTH; PAIN; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SCORING SYSTEM; SOCIAL INTERACTION;

EID: 1842607642     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1087-0024.2004.09115.x     Document Type: Article

References (17)

1. Aaronson NK, Muller M, Cohen PDA, et al: Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055-1068, 1998
2. Chren MM, Lasek RJ, Quinn LM, Covinsky KE: Convergent and discriminant validity of a generic and disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 108:103-107, 1997
3. De Korte J, Mombers FM, Sprangers MA, Bos JD: The suitability of quality-of-life questionnaires for psoriasis research: A systematic literature review. Arch Dermatol 138:1221-1227, 2002
4. Finlay AY, Coles EC: The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 132:236-244, 1995
5. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE: Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 137:755-760, 1997
6. Fredricksson T, Petterson U: Severe psoriasis: Oral therapy with a new retinoid. Dermatologica 157:238-244, 1978
7. Heydendael VMR, Spuls PhI, Opmeer BC, et al: Methotrexate versus cyclosporin in moderate-to-severe chronic plaque psoriasis. N Engl J Med 349:658-665, 2003
8. Kent G, al-Abadie M: The psoriasis disability index-further analyses. Clin Exp Dermatol 18:414-416, 1993
9. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T: The Impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation Patient-Memberhip Survey. Arch Dermatol 137:280-284, 2001
10. Leary MR, Rapp SR, Herbst KC, Exum ML, Feldman SR: Interpersonal concerns and psychological difficulties of psoriasis: Effects of disease severity and fear of negative evaluation. Health Psychol 17:530-536, 1998
11. Nichol MB, Margolies JE, Lippa E, Rowe M, Quell J: The application of multiple quality-of-life instruments in individuals with mid-to-moderate psoriasis. Pharmamacoeconomics 10:644-653, 1996
12. O'Neill P, Kelly P: Postal questionnaire study of disability in the community associated with psoriasis. BMJ 313:919-921, 1996
13. Rapp SR, Feldman SR, Exum L, Fleischer AB, Reboussin DM: Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41:401-407, 1999
14. Rapp SR, Feldman SR, Fleischer AB, Reboussin DM, Exum ML: Health related quality of life in psoriasis: A biopsychosocial model and measures. In: Care Management of Skin Diseases: Life Quality and Economic Impact. New York: Dekker, 1998; p 125-146
15. Touw CR, Hakkaart-van Roijen L, Verboom P, Paul C, Rutten FFH, Finlay AY: Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 144:967-972, 2001
16. Wahl A, Hanestad BR, Wiklund I, Moum T: Coping and quality of life in patients with psoriasis. Qual Life Res 8:427-433, 1999
17. Wahl A, Loge JH, Wiklund I, Hanestad BR: The burden of psoriasis: A study concerning hearth-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol 43:803-808, 2000